Now showing items 37261-37270 of 37463
CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study
(Wiley Periodicals, Inc., 2023-03-01)
BackgroundCyclin E1 (CCNE1) is a potential predictive marker and therapeutic target in tubo-ovarian high-grade serous carcinoma (HGSC). Smaller studies have revealed unfavorable associations for CCNE1 amplification and ...
Associations Among Hip Structure, Bone Mineral Density, and Strength Vary With External Bone Size in White Women
(John Wiley & Sons, Inc., 2023-03)
Bone mineral density (BMD) is heavily relied upon to reflect structural changes affecting hip strength and fracture risk. Strong correlations between BMD and strength are needed to provide confidence that structural changes ...
Recent Stressful Experiences and Suicide Risk: Implications for Suicide Prevention and Intervention in U.S. Army Soldiers
(U.S. Armed Forces, 1998-2011Wiley Periodicals, Inc., 2023-03)
Systolic pressure target after endovascular thrombectomy in acute large-vessel occlusion ischemic stroke patients: Comment on ENCHANTED2/MT
(Wiley Periodicals, Inc., 2023-03)
Significance of barrier membrane on the reconstructive therapy of peri-implantitis: A randomized controlled trial
(Wiley Periodicals, Inc., 2023-03)
BackgroundThe objective of this trial was to investigate the clinical and radiographic significance of using a mixture of mineralized and demineralized allografts in combination (M) or not (NM) with a resorbable cross-linked ...
In memoriam: Bernard W. Agranoff (1926–2022)
(Oxford University PressWiley Periodicals, Inc., 2023-03)
Biomimetic antimicrobial polymers—Design, characterization, antimicrobial, and novel applications
(John Wiley & Sons, Inc., 2023-05)
Biomimetic antimicrobial polymers have been an area of great interest as the need for novel antimicrobial compounds grows due to the development of resistance. These polymers were designed and developed to mimic naturally ...
Higher mortality among lean patients with non-alcoholic fatty liver disease despite fewer metabolic comorbidities
(Wiley Periodicals, Inc., 2023-05)